HOUSE RESOLUTION NO. 91-4652, by Representatives Cantwell, Paris, Rasmussen, Wynne, Ludwig, Ferguson, Van Luven, Wood, Miller, Horn, May, Betrozoff, Sheldon, Forner and Riley

     WHEREAS, The legislature recognizes that Washington is the home of major academic, medical, and scientific research institutions that make valuable contributions to industry and the economic future of Washington state; and

     WHEREAS, Biotechnology is an important sector of our State's economy that has been identified by the Legislature as a source of new jobs and provides a competitive advantage for industries such as agriculture, forest products, and medical technology; and

     WHEREAS, The legislature has received the report of the Washington Biotechnology Targeted Sector Advisory Committee that recognizes the significant potential for growth in the industry through a coordinated and focused state-wide effort; and

     WHEREAS, The fight against cancer is an important national priority that has been led by Washington research and corporate institutions; and

     WHEREAS, The Immunex Corporation was founded in Washington, is headquartered here, and has played an important role in the fight against cancer and the development of biotechnology in Washington; and

     WHEREAS, The Food and Drug Administration has on March 5, 1991, approved Immunex's new pharmaceutical, Leukine, to be used as therapy in bone marrow transplantation as a treatment for forms of cancer and other diseases, and is being hailed as the first of a new generation of drugs; and

     WHEREAS, Leukine is the first pharmaceutical product discovered, manufactured, and sold by a Washington state company; and

     WHEREAS, Washington is fortunate to have talented researchers that have made significant advances in science and medicine;

     NOW, THEREFORE, BE IT RESOLVED, That the House of Representatives hereby salute the Immunex Corporation, the State Biotechnology Task Force, and the Biotechnology Industry, for its success, and the men and women whose work and dedication have made this important medical advance a reality; and

     BE IT FURTHER RESOLVED, That copies of this resolution be immediately transmitted by the Chief Clerk of the House of Representatives to Stephen Duzan, Chief Executive Officer of the Immunex Corporation.

         I hereby certify this to be a true and correct copy of

         Resolution 4652 adopted by the Rules Committee of the

                 House of Representatives April 1 1991.

                     ________________________________

           Alan Thompson, Chief Clerk, House of Representatives